|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$321,000
|
N/A
|
National Cancer Institute
|
|
SBIR PHASE I-VITA-CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD.
|
261201500011C
|
$291,250
|
|
"CHEN, PH.D.", WEN-TIEN
|
VITATEX, INC.
|
|
NEXT: SILVESTROL; TO18 DOSE RANGE-FINDING STUDY AND PHARMAKINETICS OF ROCAGLAMIDE
|
261201100027C
|
$226,876
|
|
"MCCORMICK, PH.D., D.A.B.T.", DAVID
|
IIT RESEARCH INSTITUTE
|
|
p53 - Regulators and Effectors
|
3P01CA080058-15S1
|
$70,000
|
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
WNT Receptor Signaling and Cancer
|
5R01CA071672-12
|
$384,540
|
$384,540
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Training Program in Cancer Biology
|
5T32CA078207-10
|
$443,412
|
$146,326
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Detection of Melanoma by Canine Olfactory Receptors.
|
1R21CA132046-01A1
|
$206,550
|
$206,550
|
Abaffy, Tatjana
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Molecular mechanisms of prostate cancer metastasis
|
1R01CA183929-01A1
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
|
5R01CA114095-03
|
$300,311
|
$300,311
|
ABDEL-MALEK, ZALFA
|
UNIVERSITY OF CINCINNATI
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-08
|
$284,744
|
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
1R01CA172105-01A1
|
$401,456
|
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Discovering the spectrum of natural somatic mosaicism in human skin fibroblasts
|
1R03CA191421-01A1
|
$96,085
|
|
ABYZOV, ALEXEJ
|
MAYO CLINIC ROCHESTER
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$206,036
|
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$824,145
|
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$31,655
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
Regulation of Oncogene-Induced Senescence by Wnt-Signaling
|
1R01CA129334-01A1
|
$323,233
|
$161,617
|
ADAMS, PETER
|
INSTITUTE FOR CANCER RESEARCH
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Regulation of Gene Transcription
|
ZIA BC 008751
|
$962,058
|
|
Adhya, Sankar
|
CCR (NCI)
|
|
Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced Costimulation
|
5R01CA109339-11
|
$223,722
|
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
1U01CA190234-01
|
$667,612
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$104,749
|
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Contribution of Y-specific Genes to Bladder Cancer
|
ZIA BC 011591
|
$69,833
|
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene
|
ZIA BC 011592
|
$139,666
|
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigentic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$34,916
|
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$34,916
|
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Organ specific macrophages and the regulation of disseminated tumor cell fate
|
1R03CA191430-01
|
$84,750
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Functional determinants of metastatic dormancy
|
5R01CA109182-04
|
|
$0
|
AGUIRRE-GHISO, JULIO
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-12
|
$143,777
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Functional determinants of metastatic dormancy
|
7R01CA109182-05
|
$303,516
|
$75,879
|
AGUIRRE-GHISO, JULIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-10
|
$262,280
|
|
AHMED, YASMATH
|
DARTMOUTH COLLEGE
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-05
|
$292,333
|
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
SON and the MALAT1 locus in chromatin interaction and metastasis gene regulation
|
1R21CA185818-01A1
|
$197,164
|
|
AHN, ERIN
|
UNIVERSITY OF SOUTH ALABAMA
|
|
Signal Transduction Pathways in Melanoma
|
5R01CA118972-02
|
$268,701
|
$268,701
|
AHN, NATALIE
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
Genetic Susceptibility to Arsenic-induced Skin Cancer
|
5R01CA102484-05
|
$384,390
|
$384,390
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Chemoprevention of arsenic-induced skin cancer
|
5R01CA107431-04
|
$1,511,506
|
$1,133,630
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-02
|
$296,906
|
$148,453
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Defining the role of Id1 in melanoma development
|
5R01CA107017-05
|
$244,169
|
$244,169
|
ALANI, RHODA
|
JOHNS HOPKINS UNIVERSITY
|
|
Prospective study of farmers and their families (Agricultural health study)
|
Z01 CP010119-02020
|
$1,233,935
|
$123,394
|
Alavanja, Michael
|
DCEG (NCI)
|
|
DNA Repair, Skin Cancer and Overall Cancer Risk
|
5R01CA105069-04
|
$397,869
|
$397,869
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-09
|
$446,225
|
$22,311
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$832,381
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$21,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT
|
5P01CA027502-27
|
$3,780,708
|
$3,780,708
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-09
|
$511,052
|
$51,105
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
HHSN261201300055C; PROJECT TITLE: COMPASS SYSTEM MODIFICATION; PERIOD OF PERFORM
|
261201300055C
|
$149,925
|
|
ALBINALI, FAHD
|
EVERY FIT, INC.
|
|
p90RSK2-Stathmin Signaling in Metastatic Human Cancers
|
5F31CA183365-02
|
$43,120
|
|
ALESI, GINA
|
EMORY UNIVERSITY
|
|
Interleukin-4 Drives Tumor-Associated Macrophage Polarization to Promote Tumor Gr
|
5F30CA173910-02
|
$48,056
|
|
ALLEN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
Total relevant funding to Skin for this search: $190,565,481
|